BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 21646485)

  • 1. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
    Kim H; Nakajima C; Yokoyama K; Rahim Z; Kim YU; Oguri H; Suzuki Y
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3661-7. PubMed ID: 21646485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
    Pantel A; Petrella S; Veziris N; Brossier F; Bastian S; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1990-6. PubMed ID: 22290942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
    Matrat S; Aubry A; Mayer C; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2909-14. PubMed ID: 18426901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.
    Aubry A; Pan XS; Fisher LM; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1281-8. PubMed ID: 15047530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
    Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
    Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimurium.
    Kongsoi S; Changkwanyeun R; Yokoyama K; Nakajima C; Changkaew K; Suthienkul O; Suzuki Y
    Drug Test Anal; 2016 Oct; 8(10):1065-1070. PubMed ID: 26514939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
    Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino Acid Substitution Ser83Ile in GyrA of DNA Gyrases Confers High-Level Quinolone Resistance to Nontyphoidal
    Koide K; San LL; Pachanon R; Park JH; Ouchi Y; Kongsoi S; Utrarachkij F; Nakajima C; Suzuki Y
    Microb Drug Resist; 2021 Oct; 27(10):1397-1404. PubMed ID: 33877914
    [No Abstract]   [Full Text] [Related]  

  • 9. Quinolone resistance-associated amino acid substitutions affect enzymatic activity of Mycobacterium leprae DNA gyrase.
    Yamaguchi T; Yokoyama K; Nakajima C; Suzuki Y
    Biosci Biotechnol Biochem; 2017 Jul; 81(7):1343-1347. PubMed ID: 28417702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of lineage-specific amino acid dimorphisms in GyrA on Mycobacterium tuberculosis resistance to fluoroquinolones.
    Kim H; Nakajima C; Kim YU; Yokoyama K; Suzuki Y
    Jpn J Infect Dis; 2012; 65(1):72-4. PubMed ID: 22274162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of mutations in DNA gyrase genes on quinolone resistance in Campylobacter jejuni.
    Changkwanyeun R; Yamaguchi T; Kongsoi S; Changkaew K; Yokoyama K; Kim H; Suthienkul O; Usui M; Tamura Y; Nakajima C; Suzuki Y
    Drug Test Anal; 2016 Oct; 8(10):1071-1076. PubMed ID: 26857529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
    Thapa J; Chizimu JY; Kitamura S; Akapelwa ML; Suwanthada P; Miura N; Toyting J; Nishimura T; Hasegawa N; Nishiuchi Y; Gordon SV; Nakajima C; Suzuki Y
    Microbiol Spectr; 2023 Jun; 11(3):e0508822. PubMed ID: 37067420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
    Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
    Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
    Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Characterization of the DNA Gyrases in Fluoroquinolone-Resistant Mutants of Francisella novicida.
    Caspar Y; Siebert C; Sutera V; Villers C; Aubry A; Mayer C; Maurin M; Renesto P
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA gyrase from the albicidin producer Xanthomonas albilineans has multiple-antibiotic-resistance and unusual enzymatic properties.
    Hashimi SM; Huang G; Maxwell A; Birch RG
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1382-90. PubMed ID: 18268084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
    Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
    Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
    Matrat S; Veziris N; Mayer C; Jarlier V; Truffot-Pernot C; Camuset J; Bouvet E; Cambau E; Aubry A
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4170-3. PubMed ID: 17015625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.